| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net interest income before provision for credit losses | NaN | 38,042,792 | NaN |
| Net interest income after provision for credit losses | NaN | 38,042,792 | NaN |
| Salaries and employee benefits | NaN | 311,441 | NaN |
| Professional fees | NaN | 700,395 | NaN |
| Other | NaN | 349,926 | NaN |
| Total noninterest expense | NaN | 1,361,762 | NaN |
| Income before income tax benefits | NaN | 36,681,030 | NaN |
| Provision for income tax benefits | NaN | -515,168 | NaN |
| Net income | 9,534,438 | 10,138,851 | 27,057,347 |
| Amortization of core deposit intangible | 375,341 | 1,568,586 | NaN |
| Amortization and (accretion), net | -62,166 | -1,598,547 | -46,198 |
| Provision for credit losses | 121,970 | 463,326 | NaN |
| Stock compensation expense | 159,414 | 124,375 | NaN |
| Provision for losses on foreclosed assets | NaN | 0 | 4,500 |
| Deferred income taxes | NaN | -120,274 | 348,067 |
| Loss on retirement of debt | -603,303 | NaN | NaN |
| Net gains on sales of foreclosed assets | 106,553 | 47,726 | 113,270 |
| Interest receivable | 186,782 | 354,108 | -90,367 |
| Other assets | -1,399,818 | -204,957 | -8,417,887 |
| Other liabilities | 1,584,824 | -1,334,171 | -6,799,212 |
| Bank owned life insurance | 311,643 | 342,379 | 949,557 |
| Interest payable | -317,579 | -448,220 | -814,601 |
| Depreciation | 557,818 | 618,680 | 1,519,018 |
| Net gains on sales of premises and equipment | 0 | 12,646 | 24,959 |
| Net cash provided by operating activities | 13,352,203 | 9,101,252 | 27,993,255 |
| Proceeds from, maturities and calls of available-for-sale securities | 875,596 | 1,331,262 | 36,586,565 |
| Proceeds from, maturities and calls of held-to-maturity securities | 1,285,694 | 49,395,123 | 85,464,673 |
| Net change in loans | 19,105,771 | 106,855,210 | -39,254,790 |
| Purchase of premises and equipment, net | 237,355 | 327,021 | 1,538,105 |
| Proceeds from sales of foreclosed assets | 359,553 | 592,668 | 693,625 |
| Death benefits received | NaN | 176,789 | 350,509 |
| Purchase of restricted stock, at cost | NaN | 5,559,800 | NaN |
| Proceeds from bank owned life insurance | 489,907 | NaN | NaN |
| Redemption of restricted stock, at cost | 1,136,200 | 2,348,000 | 100,450 |
| Purchases of available-for-sale securities | 0 | 14,830,375 | 16,929,788 |
| Purchases of held-to-maturity securities | 0 | 15,092,578 | 88,100,756 |
| Payments relating to foreclosed assets | NaN | -11,989 | NaN |
| Proceeds from sales of premises and equipment | 0 | 223,809 | 64,400 |
| Net cash used in investing activities | -15,196,176 | -88,609,322 | 55,946,363 |
| Net (decrease) increase in deposits | 76,483,023 | 35,100,523 | -157,963,373 |
| Proceeds from (repayments of) short-term borrowings | -43,183,448 | 184,954,724 | NaN |
| Repayments of short-term borrowings | NaN | 100,095,000 | NaN |
| Proceeds from (repayments of) short-term borrowings | NaN | NaN | 59,270,961 |
| Proceeds from long-term borrowings | NaN | 8,330,500 | NaN |
| Issuance of common stock, net | NaN | 29,860,751 | NaN |
| Repayments of long-term borrowings | 6,010,138 | 29,840,482 | 5,675,299 |
| Payment of dividends | 1,369,799 | 0 | 2,002,079 |
| Repurchase of stock | 0 | 0 | 980,800 |
| Purchase of minority interest | 0 | NaN | NaN |
| Net cash (used in) provided by financing activities | 25,919,638 | 69,040,055 | -107,350,590 |
| (decrease) increase in cash and cash equivalents | 24,075,665 | NaN | NaN |
| (decrease) increase in cash and cash equivalents | 24,075,665 | -10,468,015 | -23,410,972 |
| Cash and cash equivalents, beginning of period | 144,318,929 | 154,786,944 | 178,197,916 |
| Cash and cash equivalents, end of period | 168,394,594 | 144,318,929 | 154,786,944 |
Commercial Bancgroup, Inc. (CBK)
Commercial Bancgroup, Inc. (CBK)